CTSO Next Earnings Date Notes

— CytoSorbents (CTSO) develops & manufactures blood purification technologies designed to treat life-threatening conditions, with its flagship product being CytoSorb®, an extracorporeal cytokine adsorber used to reduce cytokine storm & inflammatory mediators in critically ill patients. The company's products are primarily aimed at intensive care units & cardiac surgery centers, with regulatory approvals & commercial presence focused largely on Europe, while U.S. sales are mostly research- or grant-driven pending full FDA approval. When evaluating CytoSorbents' performance, investors should closely monitor key business metrics including product revenue growth (especially year-over-year changes in direct sales vs. distributor sales), gross margin trends, operating cash burn, R&D and SG&A expenses, updates on clinical trial progress (notably pivotal U.S. trials), and expansion of reimbursement or regulatory clearances in new geographies. Also critical are physician adoption rates, hospital account growth, and commentary regarding pipeline developments like new products or label expansions. During the earnings call, listen for management's outlook on sales growth, progress toward U.S. market entry, and strategic partnerships or collaborations, all of which are vital for assessing CTSO's long-term growth trajectory and ultimate path to profitability. The next confirmed earnings date for CTSO is 3/25/2026 after close.

CTSO Next Earnings Date FAQ

On this page we presented the CTSO Next Earnings Date information for CytoSorbents along with recent past earnings dates. For Q3 of 2025, CTSO reported earnings of -0.040/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, CTSO reported earnings of -0.050/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, CTSO reported earnings of -0.060/share, with the earnings report taking place on 5/14/2025. For Q4 of 2024, CTSO reported earnings of -0.140/share, with the earnings report taking place on 3/31/2025. For Q4 of 2024, CTSO reported earnings of /share, with the earnings report taking place on 3/6/2025. And with these past earnings dates behind CTSO, investors can look ahead to the next confirmed earnings date of 3/25/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as CytoSorbents. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to CytoSorbents shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research CytoSorbents next earnings dates as well as any other stock out there in our coverage universe, to see when the next CTSO earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CTSO's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CTSO next earnings date.